REV CLINICAL Trademark

Trademark Overview

On Thursday, November 6, 2025, a trademark application was filed for REV CLINICAL with the United States Patent and Trademark Office. The USPTO has given the REV CLINICAL trademark a serial number of 99483375. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Thursday, November 6, 2025. This trademark is owned by CBCC Global Research, LLC. The REV CLINICAL trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

clinical research organization (CRO) services, namely conducting clinical trials for medical device and pharmaceutical drug development in the field of oncology and rare diseases for others
rev clinical

General Information

Serial Number99483375
Word MarkREV CLINICAL
Filing DateThursday, November 6, 2025
Status630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
Status DateThursday, November 6, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and Servicesclinical research organization (CRO) services, namely conducting clinical trials for medical device and pharmaceutical drug development in the field of oncology and rare diseases for others

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, November 6, 2025
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameCBCC Global Research, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressBakersfield, CA 93309

Trademark Events

Event DateEvent Description
Thursday, November 6, 2025NEW APPLICATION ENTERED
Thursday, November 6, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, November 6, 2025APPLICATION FILING RECEIPT MAILED

Related Keywords

clinical development drug field oncology others diseases rare pharmaceutical device